# Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)

> **NCT06963268** · PHASE3 · RECRUITING · sponsor: **Instituto de Investigacion Sanitaria La Fe** · enrollment: 200 (estimated)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **PROCEDURE:** Sentinel Node Technique

## Key facts

- **NCT ID:** NCT06963268
- **Lead sponsor:** Instituto de Investigacion Sanitaria La Fe
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-10
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-19

## Collaborators

- Hospital Universitario La Fe
- Hospital Clinic of Barcelona
- Hospital Universitario 12 de Octubre
- Hospital Universitario La Paz
- Hospital General Universitario Gregorio Marañon
- Quirón Madrid University Hospital
- Hospital of Navarra
- Hospital Son Espases
- Hospital Universitari de la Vall de Hebron
- Hospital Universitario Fundación Jiménez Díaz
- Clinica Universidad de Navarra, Universidad de Navarra

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06963268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06963268, "Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06963268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*